The Medicines Patent Pool (MPP) commits to facilitating access to the best available medicines for children. Specifically, the MPP will continue to work with patent holders to in-license paediatric drugs as prioritized by the WHO/PADO, and to sublicense to generic manufacturers to ensure that appropriate formulations are rapidly developed, registered and made available in as many developing countries as possible.

Medecines Patent Pool (MPP)

-

-

-

-

-

-

-

-

-

-

-

-

Sub-Actions & Milestones

Updates

Notes

Responsible